Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline
Henning, M.; Rubenson, A.
Journal of Pharmacy and Pharmacology 23(6): 407-411
1971
ISSN/ISBN: 0022-3573 PMID: 4397178 Document Number: 30928
Document emailed within 1 workday
Related Documents
Jiménez Casado, M.; Canto, J.; Yapur, H.; Oller, J.M. 1984: Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa Revista Clinica Espanola 174(1-2): 41-44Rubenson, A. 1971: Analysis of the action of m-tyrosine on blood pressure in the conscious rat: evidence for a central hypotensive effect Journal of Pharmacy and Pharmacology 23(6): 412-419
Salmon, G.K.; Ireson, J.D. 1970: A correlation between the hypotensive action of methyldopa and its depression of peripheral sympathetic function Archives Internationales de Pharmacodynamie et de Therapie 183(1): 60-64
Spach, M.O.; Imbs, J.L.; Bloch, R.; Schwartz, J. 1971: A major hypotensive drug with central action: catapressan La Presse Medicale 79(3): 101
van Zwieten, P.A. 1973: The central action of antihypertensive drugs, mediated via central alpha-receptors Journal of Pharmacy and Pharmacology 25(2): 89-95
Domino, E.F.; Krutak-Krol, H.; Lal, J. 1985: Evidence for a central site of action for the antitussive effects of caramiphen Journal of Pharmacology and Experimental Therapeutics 233(1): 249-253
Chodoff, P. 1972: Evidence for central adrenergic action of ketamine: Report of a case Anesthesia and Analgesia 51(2): 247-250
Rasenick, M.M.; Chaney, K.A.; Chen, J. 1996: G protein-mediated signal transduction as a target of antidepressant and antibipolar drug action: evidence from model systems Journal of Clinical Psychiatry 57(Suppl): 49-55; Discussion 56-58
Garbossa, G.; Gutnisky, A.; Nesse, A. 1994: The inhibitory action of aluminum on mouse bone marrow cell growth: evidence for an erythropoietin- and transferrin-mediated mechanism Mineral and Electrolyte Metabolism 20(3): 141-146
Ksiazek, A.; Kleinrok, Z. 1974: Central action of drugs affecting beta-adrenergic receptor. II. the central action of intraventricularly applicated propranolol in rats Polish Journal of Pharmacology and Pharmacy 26(3): 297-304
Tayo, F.M. 1981: Further studies on the mechanism of action of methyldopa on the vas deferens of the guinea-pig Archives Internationales de Pharmacodynamie et de Therapie 254(1): 38-42
Tsai, J.C.; Knoblich, G.; Sebanz, N. 2010: From action expertise to shared action plans: Inclusion of non-controlled actions at the intra- and inter-personal level International Journal of Psychophysiology 77(3): 332-333
Campbell, N.R.; Campbell, R.R.; Hasinoff, B.B. 1990: Ferrous sulfate reduces methyldopa absorption: methyldopa: iron complex formation as a likely mechanism Clinical and Investigative Medicine. Medecine Clinique et Experimentale 13(6): 329-332
Thomas, G.P.; Stephen, P.M. 1993: Protective action of methyldopa against ouabain-induced cardiac arrhythmias and lethality Archives Internationales de Pharmacodynamie et de Therapie 323: 23-31
Huysmans, F.T.; Thien, T.; Koene, R.A. 1979: Hypotensive action of prazosin New England Journal of Medicine 300(23): 1335-1336
Porsius, A.J.; Van Zwieten, P.A. 1978: The central actions of nicotine on blood pressure and heart rate after administration via the left vertebral artery of anaesthetized cats. Distribution of nicotine into the brain after central application Arzneimittel-Forschung 28(9): 1628-1631
Ohkubo, K.; Suzuki, K.; Oguma, M.; Otorii, T. 1982: Central hypotensive effects of guanfacine in anaesthetised rabbits Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 79(4): 263-274
Gmiński, J.; Stajszczyk, M. 1996: Anti-atherosclerotic action of hypotensive drugs Wiadomosci Lekarskie 49(7-12): 182-198
Yamamoto, M.; Kumagai, A.; Yamamura, Y. 1975: Structure and action of saikosaponins isolated from Bupleurum falcatum L. II. Metabolic actions of saikosaponins, especially a plasma cholesterol-lowering action Arzneimittel-Forschung 25(8): 1240-1243
Pang, P.K.; Yang, M.C.; Tenner, T.E.; Chang, J.K.; Shimizu, M. 1981: Hypotensive action of synthetic fragments of parathyroid hormone Journal of Pharmacology and Experimental Therapeutics 216(3): 567-571